[ 1 ] Dannenberg AJ, Altorki NK, Boyle JO, et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cance[J]. Lancet Oncol, 2001, 2(9): 544-551.
[2]
[ 2 ] Howe LR, Dannenberg AJ. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer[J]. Semin Oncol, 2002, 29 (3 Suppl 11): 111-119.
[3]
[ 3 ] Yang XG, Zhang HZ, Wei L, et al. The expression of cyclooxygenase-2 (Cox-2) and p16 in non-Hodgkin’s lymphomas and its climcal significance[J]. Chinese-German Clin Oncol, 2009, 8(2): 104-109．
[4]
[ 4 ] Ferrandina G, Lauriola L, Distefano MG, et al. Increased cycloxygenase-2 expression is associated with chemotherapy resistance and poor surviral in cervical cancer patients[J]. J Clin Oncol, 2002, 20(4)：973-981．
[5]
[ 5 ] Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma[J]. Clin Cancer Res, 2000, 6(2)：519-525．
[6]
[ 6 ] van Rees BP, Saukkonen K, Ristimaki A, et al. Cyclooxygenase-2 overexpression during carcinogenesis in the human stomach[J]. J Pathol, 2002, 196(2)：171-179.
[7]
[ 7 ] Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2[J]. Cell, 1995, 83(3): 493-501.
[8]
[ 8 ] Jones MK, Wang H, Peskar BM, et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs:insight into mechanisms and implications for cancer growth and ulcer healing[J]. Nat Med, 1999, 5(12): 1418-1423.
[9]
[ 9 ] McGinty A, Chang YW, Sorokin A, et al. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor -differentiated PC12 cells[J]. J Biol Chem, 2000, 275(16): 12095-12101.
[10]
Kishimoto Y, Yashima K, Morisawa T, et al. Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane[J]. J Gastroenterol, 2002, 37(3): 186-193.
